ONCOLYTICS BIOTECH INC. Stock-Based Compensation
ONCOLYTICS BIOTECH INC. (ONCY) reported Stock-Based Compensation of $4.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- ONCOLYTICS BIOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.79M, a 393.92% increase year-over-year.
- ONCOLYTICS BIOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.30M, a 172.07% increase year-over-year.
- ONCOLYTICS BIOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $362.00K.
- ONCOLYTICS BIOTECH INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $845.00K.
- ONCOLYTICS BIOTECH INC. share-based payment arrangement, noncash expense for fiscal 2025 was $3.10M, a 56.61% increase from fiscal 2024.
- ONCOLYTICS BIOTECH INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.98M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.09M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $2.30M 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $3.10M 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.21M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $845.00K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $1.98M 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |